A review committee for the RUSP will look at approved treatments, how the disease has developed in the U.S., evidence that pre-symptom treatments are effective, and any data from pilot screenings. They’ll also determine whether or not there’s a reliable diagnostic test available. The committee is due to take comments regarding the inclusion of SMA in May. The acceptance process could take around a year.
If accepted, it will then be up to individual states to decide whether to screen newborns for SMA. Find out more about this story here.
Screenings at birth will allow those affected by the disease to begin care immediately and get the most out of the treatments available. It will also spare babies and families months of diagnostic tests.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.